文献速递脑血管病外科

Onyx栓塞对伽玛刀动静脉畸形剂量分布的剂量学影响

Dosimetric effects of Onyx embolization on Gamma Knife arteriovenous malformation dose distributions.
PubMed 文献 · J Neurosurg · 2016-01-01

本研究采用蒙特卡洛剂量计算引擎,对7例栓塞后伽玛刀治疗的动静脉畸形患者建模,比较Onyx按厂商物理常数与按水常数计算的剂量分布差异。结果显示剂量指标平均差异较小,1.0%/1.0 mm伽玛通过率高,提示这些变化不太可能具有临床意义。

要点

  • Onyx栓塞对伽玛刀射束剂量分布可产生可检测的影响。
  • 动静脉畸形最小剂量平均差异-0.7%,最大剂量平均差异2.9%。
  • 1.0%/1.0 mm伽玛通过率平均98.2%,提示变化不太可能具有临床意义。

核心结论

  • Onyx栓塞似乎对伽玛刀射束的剂量分布有可检测的影响,但剂量指标变化小且1.0%/1.0 mm容差下伽玛通过率高,提示这些变化不太可能具有临床意义。

研究设计与样本

  • 对7例栓塞后接受伽玛刀放射外科治疗的动静脉畸形患者,使用Leksell GammaPlan分割靶区和Onyx区域,结合临床剂量分布和伽玛刀Perfexion射束几何,在蒙特卡洛剂量计算引擎Pegasos中比较Onyx按厂商物理常数与按水常数的剂量分布。

主要发现

  • Onyx按厂商常数相对于按水常数,动静脉畸形最小剂量平均百分比差异为-0.7%(SD 1.4%),平均剂量为0.1%(SD 0.2%),最大剂量为2.9%(SD 5.0%),选择性指数为0.1%(SD 0.2%),覆盖率为-0.0%(SD 0.2%)。
  • 在3.0%/3.0 mm容差下,伽玛分析通过体素平均百分比为99.7%(SD 0.1%)。
  • 在1.0%/1.0 mm容差下,伽玛分析通过体素平均百分比为98.2%(SD 0.7%)。
  • 在0.5%/0.5 mm容差下,伽玛分析通过体素平均百分比为52.1%(SD 4.4%)。

临床怎么用

  • 作者认为应进一步研究其他投照和生物学不确定性来源,以确定栓塞后伽玛刀放射外科治疗结果较差的根本原因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Patients with arteriovenous malformations (AVMs) treated with Gamma Knife radiosurgery (GKRS) subsequent to embolization suffer from elevated local failure rates and differences in adverse radiation effects. Onyx is a common embolic material for AVMs. Onyx is formulated with tantalum, a high atomic number (Z = 73) element that has been investigated as a source of dosimetric uncertainty contributing to the less favorable clinical results. However, prior studies have not modeled the complicated anatomical and beam geometries characteristic of GKRS. This study investigated the magnitude of dose perturbation that can occur due to Onyx embolization using clinically realistic anatomical and Gamma Knife beam models. METHODS Leksell GammaPlan (LGP) was used to segment the AVM nidus and areas of Onyx from postcontrast stereotactic MRI for 7 patients treated with GKRS postembolization. The resulting contours, skull surface, and clinically selected dose distributions were exported from LGP in DICOM-RT (Digital Imaging and Communications in Medicine-radiotherapy) format. Isocenter locations and dwell times were recorded from the LGP database. Contours were converted into 3D mesh representations using commercial and in-house mesh-editing software. The resulting data were imported into a Monte Carlo (MC) dose calculation engine (Pegasos, Elekta Instruments AB) with a beam geometry for the Gamma Knife Perfexion. The MC-predicted dose distributions were calculated with Onyx assigned manufacturer-reported physical constants (MC-Onyx), and then compared with corresponding distributions in which Onyx was reassigned constants for water (MC-water). Differences in dose metrics were determined, including minimum, maximum, and mean dose to the AVM nidus; selectivity index; and target coverage. Combined differences in dose magnitude and distance to agreement were calculated as 3D Gamma analysis passing rates using tolerance criteria of 0.5%/0.5 mm, 1.0%/1.0 mm, and 3.0%/3.0 mm. RESULTS Overall, the mean percentage differences in dose metrics for MC-Onyx relative to MC-water were as follows; all data are reported as mean (SD): minimum dose to AVM = -0.7% (1.4%), mean dose to AVM = 0.1% (0.2%), maximum dose to AVM = 2.9% (5.0%), selectivity = 0.1% (0.2%), and coverage = -0.0% (0.2%). The mean percentage of voxels passing at each Gamma tolerance were as follows: 99.7% (0.1%) for 3.0%/3.0 mm, 98.2% (0.7%) for 1.0%/1.0 mm, and 52.1% (4.4%) for 0.5%/0.5 mm. CONCLUSIONS Onyx embolization appears to have a detectable effect on the delivered dose distribution. However, the small changes in dose metrics and high Gamma passing rates at 1.0%/1.0 mm tolerance suggest that these changes are unlikely to be clinically significant. Additional sources of delivery and biological uncertainty should be investigated to determine the root cause of the observed less favorable postembolization GKRS outcomes.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Schlesinger DJ, Nordström H, Lundin A, et al. Dosimetric effects of Onyx embolization on Gamma Knife arteriovenous malformation dose distributions. J Neurosurg. 2016. PMID: 27903195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。